Adverse events of a third dose of BNT162b2 mRNA COVID-19 vaccine among Korean healthcare workers

Due to the urgency of controlling the coronavirus disease 2019 pandemic, coronavirus disease 2019 messenger ribonucleic acid (mRNA) vaccines have been expeditiously approved and introduced in several countries without sufficient evaluation for adverse events. We analyzed adverse events among Korean...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Dong Yeop, Kang, Dong Yoon, Kim, Eunjung, Lee, Se-joo, Baek, Ji Hyeon, Lee, Jin-Soo, Park, Mi Youn, Im, Jae Hyoung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
4900
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018524/
https://www.ncbi.nlm.nih.gov/pubmed/36930126
http://dx.doi.org/10.1097/MD.0000000000033236

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018524/
https://www.ncbi.nlm.nih.gov/pubmed/36930126
http://dx.doi.org/10.1097/MD.0000000000033236

Ejemplares similares